Last update Feb. 5, 2022
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Brexanolone is also known as
Brexanolone in other languages or writings:
|Theoretical Dose||< 0.0015||mg/Kg/d|
|Relative Dose||1 - 2||%|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Progesterone metabolite, GABA-A receptor modulator, used in the treatment of postpartum depression.
Administration in continuous intravenous infusion for 60 hours.
It is excreted in human milk in a clinically non-significant amount. (FDA 2019, Hoffmann 2019)
No problems have been observed in infants whose mothers it was given. (FDA 2019)
It can cause excessive sedation and loss of consciousness during its administration, so the mother must be monitored and attended.(FDA 2019)
It is not recommended to share a bed with the baby or remain unattended while breastfeeding during the administration of the product.